Results
|
7421.
|
|
|
7422.
|
|
|
7423.
|
|
|
7424.
|
|
|
7425.
|
|
|
7426.
|
|
|
7427.
|
|
|
7428.
|
|
|
7429.
|
|
|
7430.
|
|
|
7431.
|
|
|
7432.
|
|
|
7433.
|
|
|
7434.
|
|
|
7435.
|
|
|
7436.
|
|
|
7437.
|
|
|
7438.
|
|
|
7439.
|
|
|
7440.
|
Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutations. [electronic resource] by
- Yang, Jiao
- Wang, Li-Jiao
- Liu, Jing-Jing
- Zhong, Lei
- Zheng, Ren-Lin
- Xu, Yong
- Ji, Pan
- Zhang, Chun-Hui
- Wang, Wen-Jing
- Lin, Xing-Dong
- Li, Lin-Li
- Wei, Yu-Quan
- Yang, Sheng-Yong
Producer: 20130226
In:
Journal of medicinal chemistry vol. 55
Availability: No items available.
|